United States · FDA National Drug Code directory
Therabreath Anticavity
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10237-260_53d7150b-d8de-145c-e063-6394a90ac434
- Product NDC
- 10237-260
- Form
- RINSE
- Composition / generic term
- SODIUM FLUORIDE
- Labeler
- Church & Dwight Co., Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20230213
- Source listing expiry
- 20271231
Source-listed ingredients
- SODIUM FLUORIDE — .005 mg/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 88.7 mL in 1 BOTTLE, PLASTIC (10237-260-03) · 10237-260-03
- 10 PACKET in 1 CARTON (10237-260-10) / 10 mL in 1 PACKET · 10237-260-10
- 473 mL in 1 BOTTLE, PLASTIC (10237-260-16) · 10237-260-16
- 20 POUCH in 1 CARTON (10237-260-20) / 10 mL in 1 POUCH · 10237-260-20
- 2 BOTTLE in 1 PACKAGE (10237-260-26) / 473 mL in 1 BOTTLE · 10237-260-26
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →